| Name | L-lysine |
|---|---|
| Synonyms |
(2S)-2,6-Diaminocaproic acid, (2S)-2,6-Diaminohexanoic acid
L-Lysine (9CI) (l)-lysine lysineacid LYSINE, L-(+) L-LysineSolutionInWater ginine Impurity A ginine Impurity 1(ginine Impurity A)(Lysine) Lysine acid L-Lysine, l.s L-Lysine (Titration) L-LYSINE, ( EE/GLC) (S)-(+)-LYSINE alpha-Lysine (S)-2,6-diamino-Hexanoic acid MFCD00064433 L-LYSINE SOLUTION, IN WATER alpha,silon-Diaminocaproic acid H-Lys-OH L-Lys-OH lys(iupacabbreviation) (+)-S-Lysine LYSINE L-LYSINE MONOHYDRATE (S)-a,e-Diaminocaproic acid L-LYSINE BASE (S)-a,e-Diaminocaproic Acid Lysinum [Latin] (S)-lysine Lysine L-Lizine cormob crystalline laiansuan 2,6-diaminohexanoicacid L-Norleucine, 6-amino L-lys (S)-Diaminocaproic acid Lisina [Spanish] 2,6-DIAMINOCAPROIC ACID 2,6-Diaminohexanoic acid L-Lysine Vetec(TM) ade, >= L-(+)-LYSINE H-LYS-OH Aminutrin L-H2N(CH2)4CH(NH2)COOH (S)-2,6-DIAMINOCAPROIC ACID (S)-alpha,silon-Diaminocaproic acid L-,-Diaminoc-proicacid L(+)-LYSINE-1-HYDRATE BIOSYNTH L-Lysine Free Base L-Lysine crystallized, >= (NT) L-Lysine,(S)-2,6-Diaminocaproic acid LYSINE DIHCL, DL-(RG) L-LYSINE (BASE) 6-Amino-L-norleucine alpha,silon-diaminocaproicacid L-Lysine (non-medicinal) Lys Hexanoic acid, 2,6-diamino-, (S) (S)-(+)-Lysine L-LYSINE ALKALI L - LYSINE FREE BASE (ANHYDROUS) L-LYSINE NON-ANIMAL SOURCE, CELL CULTURE TESTED L-LYSINE CRYST. ADE NEODIMIUM STAND L-LYSINE BASE MONOHYDRATE L-LYSIN, KRISTALLISIERT Aminutrin, 6-amino FEMA 3847 l-lysine solution EINECS 200-294-2 L-lysine zwitterion |
| Description | L-lysine is an essential amino acid[1][2] with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions[2]. |
|---|---|
| Related Catalog | |
| Target |
L-lysine (150 mg/kg) promotes, but not initiates, bladder cancer. The administration of L-lysine to rats submitted to colovesical cystoplasty accelerates the development of transitional metaplasia of the intestinal epithelium[1]. L-lysine (10 mg/kg) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity[2]. |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 311.5±32.0 °C at 760 mmHg |
| Melting Point | 215 °C (dec.)(lit.) |
| Molecular Formula | C6H14N2O2 |
| Molecular Weight | 146.188 |
| Flash Point | 142.2±25.1 °C |
| Exact Mass | 146.105530 |
| PSA | 89.34000 |
| LogP | -1.04 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.503 |
| Storage condition | Store at RT. |
| Stability | Stable. Incompatible with strong oxidizing agents. |
| Water Solubility | H2O: 0.1 g/mL, clear, colorless |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | OL5540000 |
| HS Code | 2922411000 |
| Precursor 4 | |
|---|---|
| DownStream 10 | |
| HS Code | 2922411000 |
|---|---|
| Summary | HS: 2922411000. 2,6-diaminohexanoic acid. VAT:17.0%. tax rebate rate:9.0%. supervision conditions:ab(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tarrif:5.0%. general tariff:20.0% |